Literature DB >> 10802667

Mice deficient in Six5 develop cataracts: implications for myotonic dystrophy.

T R Klesert1, D H Cho, J I Clark, J Maylie, J Adelman, L Snider, E C Yuen, P Soriano, S J Tapscott.   

Abstract

Expansion of a CTG trinucleotide repeat in the 3' UTR of the gene DMPK at the DM1 locus on chromosome 19 causes myotonic dystrophy, a dominantly inherited disease characterized by skeletal muscle dystrophy and myotonia, cataracts and cardiac conduction defects. Targeted deletion of Dm15, the mouse orthologue of human DMPK, produced mice with a mild myopathy and cardiac conduction abnormalities, but without other features of myotonic dystrophy, such as myotonia and cataracts. We, and others, have demonstrated that repeat expansion decreases expression of the adjacent gene SIX5 (refs 7,8), which encodes a homeodomain transcription factor. To determine whether SIX5 deficiency contributes to the myotonic dystrophy phenotype, we disrupted mouse Six5 by replacing the first exon with a beta-galactosidase reporter. Six5-mutant mice showed reporter expression in multiple tissues, including the developing lens. Homozygous mutant mice had no apparent abnormalities of skeletal muscle function, but developed lenticular opacities at a higher rate than controls. Our results suggest that SIX5 deficiency contributes to the cataract phenotype in myotonic dystrophy, and that myotonic dystrophy represents a multigenic disorder.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10802667     DOI: 10.1038/75490

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  61 in total

1.  Expression of evolutionarily conserved eye specification genes during Drosophila embryogenesis.

Authors:  J P Kumar; K Moses
Journal:  Dev Genes Evol       Date:  2001-09       Impact factor: 0.900

Review 2.  Does (CUG)n repeat in DMPK mRNA 'paint' chromosome 19 to suppress distant genes to create the diverse phenotype of myotonic dystrophy?: A new hypothesis of long-range cis autosomal inactivation.

Authors:  R P Junghans; A Ebralidze; B Tiwari
Journal:  Neurogenetics       Date:  2001-03       Impact factor: 2.660

Review 3.  Neurodegeneration the RNA way.

Authors:  Abigail J Renoux; Peter K Todd
Journal:  Prog Neurobiol       Date:  2011-11-03       Impact factor: 11.685

4.  Six and Eya expression during human somitogenesis and MyoD gene family activation.

Authors:  Françoise Fougerousse; Muriel Durand; Soledad Lopez; Laurence Suel; Josiane Demignon; Charles Thornton; Hidenori Ozaki; Kyoshi Kawakami; Patrick Barbet; Jacques S Beckmann; Pascal Maire
Journal:  J Muscle Res Cell Motil       Date:  2002       Impact factor: 2.698

Review 5.  Epigenetics in nucleotide repeat expansion disorders.

Authors:  Fang He; Peter K Todd
Journal:  Semin Neurol       Date:  2012-01-21       Impact factor: 3.420

Review 6.  Epigenetic changes and non-coding expanded repeats.

Authors:  Masayuki Nakamori; Charles Thornton
Journal:  Neurobiol Dis       Date:  2010-02-18       Impact factor: 5.996

7.  Dystrophia myotonia: why focus on foci?

Authors:  R P Junghans
Journal:  Eur J Hum Genet       Date:  2009-01-28       Impact factor: 4.246

Review 8.  Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2.

Authors:  Laura P W Ranum; John W Day
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

Review 9.  Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy.

Authors:  N Muge Kuyumcu-Martinez; Thomas A Cooper
Journal:  Prog Mol Subcell Biol       Date:  2006

Review 10.  Antisense oligonucleotides: rising stars in eliminating RNA toxicity in myotonic dystrophy.

Authors:  Zhihua Gao; Thomas A Cooper
Journal:  Hum Gene Ther       Date:  2013-01-30       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.